Scientech Research’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
Other funds holding MYGN
Scientech Research's MYGN Position: Q2 2026 in Review
Scientech Research sold out of Myriad Genetics (MYGN) in Q2 2026, closing a stake of 12,377 shares — an estimated $55.7K sold.
Scientech Research first reported a position in MYGN in Q1 2026 and held it in 1 quarter. The position peaked at $55.7K in Q1 2026. 199 funds tracked by Wall St. Rank hold MYGN as of Q2 2026.
- Scientech Research reported no remaining Myriad Genetics position as of Q2 2026 after selling out during the quarter.
- Scientech Research sold 12,377 Myriad Genetics shares in Q2 2026, an estimated $55.7K.
- Scientech Research first reported a position in Myriad Genetics in Q1 2026 and held it in 1 quarter.
- Scientech Research's Myriad Genetics position peaked at $55.7K in Q1 2026.
- 199 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2026.
Based on Scientech Research's 13F filing for Q2 2026, filed 14 Aug 2026.